Grants Awarded

  • All
  • LCH
  • Rare Histiocytic Disorders and Other Topics
  • RDD

Janus Kinase Inhibition as a Novel Treatment for Hemophagocytic Lymphohistiocytosis

Principal Investigator Kim E. Nichols, MD University of Pennsylvania Perelman School of Medicine The Children’s Hospital of…

Read More

Gene Therapy in a Mouse Model of Virus-triggered X-linked Lymphoproliferative Disease (XLP1): Control of Infection and Disease Progression

Principal Investigator Peter Aichele, PhD University Medical Center Freiburg, University of Freiburg – Freiburg, Germany Date of…

Read More

Unraveling the Pathophysiological Role of the BRAFV600E Mutation in Langerhans Cell Histiocytosis (LCH) and its Therapeutical Implications with Murine Models of High-Risk LCH

Principal Investigator Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai – New York, New…

Read More

Histiocyte Society Clinical Trials Database System LCH-IV Treatment Protocol Study

Project Administrators Histiocyte Society Executive Board LCH Study Reference Center – Vienna, Austria Date of Award December…

Read More

Dysregulation of Dendritic Cell Development in Langerhans Cell Histiocytosis

Principal Investigator Matthew Collin, MD Newcastle University – Newcastle upon Tyne, United Kingdom Date of Award December…

Read More